aveni

aveni is the leading developer and supplier of Electrografting™ chemistries and processes for the semiconductor and electronics industry. Headquartered in Massy, France, the company has a worldwide reputation for providing transformative chemistries and processes, coupled with the technology transfer capability to enable smooth transition of its solutions into production. For more information, visit aveni.com

https://aveni.com/

Team Members
more about
Roel Bulthuis
more about
Christian Patze
Latest News Entry
2017/10/24
aveni® S.A. Raises €8.9M ($10.5M) in Series B Financing from Merck Ventures and Existing Investors to Commercialize its Innovative Metallization Technologies

PARIS, France – October 24, 2017 aveni S.A., developer and manufacturer of market disrupting wet deposition technologies and chemistries for 2D interconnects and 3D TSV packaging, today announced it has completed a €8.9M ($10.5M) capital raise from Merck Ventures, the corporate venture arm of Merck, along with existing investors.

all portfolio news